The global market for Breast Cancer Liquid Biopsy was valued at US$ 1753 million in the year 2024 and is projected to reach a revised size of US$ 2455 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Breast Cancer Liquid Biopsy Market

Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.

North American market for Breast Cancer Liquid Biopsy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Breast Cancer Liquid Biopsy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Breast Cancer Liquid Biopsy in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Breast Cancer Liquid Biopsy include QIAGEN, Roche Diagnostics, Bio-Rad Laboratories, Myriad Genetics, Menarini Silicon Biosystems, Genomic Health, Thermo Fisher Scientific, Illumina, Biocept, Trovagene, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Breast Cancer Liquid Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Liquid Biopsy.

The Breast Cancer Liquid Biopsy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Breast Cancer Liquid Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Breast Cancer Liquid Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Breast Cancer Liquid Biopsy Market Report

Report Metric	Details
Report Name	Breast Cancer Liquid Biopsy Market
Accounted market size in year	US$ 1753 million
Forecasted market size in 2031	US$ 2455 million
CAGR	5.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Circulating Tumor Cells (CTCs) Cell-Free DNA (CfDNA) Extracellular Vesicles (EVs) Other Circulating Biomarkers
Segment by Application	Hospitals Diagnostic Centers Laboratories
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	QIAGEN, Roche Diagnostics, Bio-Rad Laboratories, Myriad Genetics, Menarini Silicon Biosystems, Genomic Health, Thermo Fisher Scientific, Illumina, Biocept, Trovagene, Guardant Health, RainDance Technologies, MDx Health
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Cancer Liquid Biopsy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Breast Cancer Liquid Biopsy Market growing?

Ans: The Breast Cancer Liquid Biopsy Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Breast Cancer Liquid Biopsy Market size in 2031?

Ans: The Breast Cancer Liquid Biopsy Market size in 2031 will be US$ 2455 million.

Who are the main players in the Breast Cancer Liquid Biopsy Market report?

Ans: The main players in the Breast Cancer Liquid Biopsy Market are QIAGEN, Roche Diagnostics, Bio-Rad Laboratories, Myriad Genetics, Menarini Silicon Biosystems, Genomic Health, Thermo Fisher Scientific, Illumina, Biocept, Trovagene, Guardant Health, RainDance Technologies, MDx Health

What are the Application segmentation covered in the Breast Cancer Liquid Biopsy Market report?

Ans: The Applications covered in the Breast Cancer Liquid Biopsy Market report are Hospitals, Diagnostic Centers, Laboratories

What are the Type segmentation covered in the Breast Cancer Liquid Biopsy Market report?

Ans: The Types covered in the Breast Cancer Liquid Biopsy Market report are Circulating Tumor Cells (CTCs), Cell-Free DNA (CfDNA), Extracellular Vesicles (EVs), Other Circulating Biomarkers

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Circulating Tumor Cells (CTCs)

1.2.3 Cell-Free DNA (CfDNA)

1.2.4 Extracellular Vesicles (EVs)

1.2.5 Other Circulating Biomarkers

1.3 Market by Application

1.3.1 Global Breast Cancer Liquid Biopsy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Diagnostic Centers

1.3.4 Laboratories

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Breast Cancer Liquid Biopsy Market Perspective (2020-2031)

2.2 Global Breast Cancer Liquid Biopsy Growth Trends by Region

2.2.1 Global Breast Cancer Liquid Biopsy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Breast Cancer Liquid Biopsy Historic Market Size by Region (2020-2025)

2.2.3 Breast Cancer Liquid Biopsy Forecasted Market Size by Region (2026-2031)

2.3 Breast Cancer Liquid Biopsy Market Dynamics

2.3.1 Breast Cancer Liquid Biopsy Industry Trends

2.3.2 Breast Cancer Liquid Biopsy Market Drivers

2.3.3 Breast Cancer Liquid Biopsy Market Challenges

2.3.4 Breast Cancer Liquid Biopsy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Breast Cancer Liquid Biopsy Players by Revenue

3.1.1 Global Top Breast Cancer Liquid Biopsy Players by Revenue (2020-2025)

3.1.2 Global Breast Cancer Liquid Biopsy Revenue Market Share by Players (2020-2025)

3.2 Global Breast Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Breast Cancer Liquid Biopsy Revenue

3.4 Global Breast Cancer Liquid Biopsy Market Concentration Ratio

3.4.1 Global Breast Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Liquid Biopsy Revenue in 2024

3.5 Global Key Players of Breast Cancer Liquid Biopsy Head office and Area Served

3.6 Global Key Players of Breast Cancer Liquid Biopsy, Product and Application

3.7 Global Key Players of Breast Cancer Liquid Biopsy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Breast Cancer Liquid Biopsy Breakdown Data by Type

4.1 Global Breast Cancer Liquid Biopsy Historic Market Size by Type (2020-2025)

4.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Type (2026-2031)

5 Breast Cancer Liquid Biopsy Breakdown Data by Application

5.1 Global Breast Cancer Liquid Biopsy Historic Market Size by Application (2020-2025)

5.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Breast Cancer Liquid Biopsy Market Size (2020-2031)

6.2 North America Breast Cancer Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Breast Cancer Liquid Biopsy Market Size by Country (2020-2025)

6.4 North America Breast Cancer Liquid Biopsy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Breast Cancer Liquid Biopsy Market Size (2020-2031)

7.2 Europe Breast Cancer Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Breast Cancer Liquid Biopsy Market Size by Country (2020-2025)

7.4 Europe Breast Cancer Liquid Biopsy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Breast Cancer Liquid Biopsy Market Size (2020-2031)

8.2 Asia-Pacific Breast Cancer Liquid Biopsy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2020-2025)

8.4 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Breast Cancer Liquid Biopsy Market Size (2020-2031)

9.2 Latin America Breast Cancer Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Breast Cancer Liquid Biopsy Market Size by Country (2020-2025)

9.4 Latin America Breast Cancer Liquid Biopsy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Breast Cancer Liquid Biopsy Market Size (2020-2031)

10.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2020-2025)

10.4 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 QIAGEN

11.1.1 QIAGEN Company Details

11.1.2 QIAGEN Business Overview

11.1.3 QIAGEN Breast Cancer Liquid Biopsy Introduction

11.1.4 QIAGEN Revenue in Breast Cancer Liquid Biopsy Business (2020-2025)

11.1.5 QIAGEN Recent Development

11.2 Roche Diagnostics

11.2.1 Roche Diagnostics Company Details

11.2.2 Roche Diagnostics Business Overview

11.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Introduction

11.2.4 Roche Diagnostics Revenue in Breast Cancer Liquid Biopsy Business (2020-2025)

11.2.5 Roche Diagnostics Recent Development

11.3 Bio-Rad Laboratories

11.3.1 Bio-Rad Laboratories Company Details

11.3.2 Bio-Rad Laboratories Business Overview

11.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Introduction

11.3.4 Bio-Rad Laboratories Revenue in Breast Cancer Liquid Biopsy Business (2020-2025)

11.3.5 Bio-Rad Laboratories Recent Development

11.4 Myriad Genetics

11.4.1 Myriad Genetics Company Details

11.4.2 Myriad Genetics Business Overview

11.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Introduction

11.4.4 Myriad Genetics Revenue in Breast Cancer Liquid Biopsy Business (2020-2025)

11.4.5 Myriad Genetics Recent Development

11.5 Menarini Silicon Biosystems

11.5.1 Menarini Silicon Biosystems Company Details

11.5.2 Menarini Silicon Biosystems Business Overview

11.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Introduction

11.5.4 Menarini Silicon Biosystems Revenue in Breast Cancer Liquid Biopsy Business (2020-2025)

11.5.5 Menarini Silicon Biosystems Recent Development

11.6 Genomic Health

11.6.1 Genomic Health Company Details

11.6.2 Genomic Health Business Overview

11.6.3 Genomic Health Breast Cancer Liquid Biopsy Introduction

11.6.4 Genomic Health Revenue in Breast Cancer Liquid Biopsy Business (2020-2025)

11.6.5 Genomic Health Recent Development

11.7 Thermo Fisher Scientific

11.7.1 Thermo Fisher Scientific Company Details

11.7.2 Thermo Fisher Scientific Business Overview

11.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Introduction

11.7.4 Thermo Fisher Scientific Revenue in Breast Cancer Liquid Biopsy Business (2020-2025)

11.7.5 Thermo Fisher Scientific Recent Development

11.8 Illumina

11.8.1 Illumina Company Details

11.8.2 Illumina Business Overview

11.8.3 Illumina Breast Cancer Liquid Biopsy Introduction

11.8.4 Illumina Revenue in Breast Cancer Liquid Biopsy Business (2020-2025)

11.8.5 Illumina Recent Development

11.9 Biocept

11.9.1 Biocept Company Details

11.9.2 Biocept Business Overview

11.9.3 Biocept Breast Cancer Liquid Biopsy Introduction

11.9.4 Biocept Revenue in Breast Cancer Liquid Biopsy Business (2020-2025)

11.9.5 Biocept Recent Development

11.10 Trovagene

11.10.1 Trovagene Company Details

11.10.2 Trovagene Business Overview

11.10.3 Trovagene Breast Cancer Liquid Biopsy Introduction

11.10.4 Trovagene Revenue in Breast Cancer Liquid Biopsy Business (2020-2025)

11.10.5 Trovagene Recent Development

11.11 Guardant Health

11.11.1 Guardant Health Company Details

11.11.2 Guardant Health Business Overview

11.11.3 Guardant Health Breast Cancer Liquid Biopsy Introduction

11.11.4 Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2020-2025)

11.11.5 Guardant Health Recent Development

11.12 RainDance Technologies

11.12.1 RainDance Technologies Company Details

11.12.2 RainDance Technologies Business Overview

11.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Introduction

11.12.4 RainDance Technologies Revenue in Breast Cancer Liquid Biopsy Business (2020-2025)

11.12.5 RainDance Technologies Recent Development

11.13 MDx Health

11.13.1 MDx Health Company Details

11.13.2 MDx Health Business Overview

11.13.3 MDx Health Breast Cancer Liquid Biopsy Introduction

11.13.4 MDx Health Revenue in Breast Cancer Liquid Biopsy Business (2020-2025)

11.13.5 MDx Health Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Menarini Silicon Biosystems

Genomic Health

Thermo Fisher Scientific

RainDance Technologies

MDx Health

List of Tables

Table 1. Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Circulating Tumor Cells (CTCs)

Table 3. Key Players of Cell-Free DNA (CfDNA)

Table 4. Key Players of Extracellular Vesicles (EVs)

Table 5. Key Players of Other Circulating Biomarkers

Table 6. Global Breast Cancer Liquid Biopsy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Breast Cancer Liquid Biopsy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Breast Cancer Liquid Biopsy Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Breast Cancer Liquid Biopsy Market Share by Region (2020-2025)

Table 10. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Breast Cancer Liquid Biopsy Market Share by Region (2026-2031)

Table 12. Breast Cancer Liquid Biopsy Market Trends

Table 13. Breast Cancer Liquid Biopsy Market Drivers

Table 14. Breast Cancer Liquid Biopsy Market Challenges

Table 15. Breast Cancer Liquid Biopsy Market Restraints

Table 16. Global Breast Cancer Liquid Biopsy Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Breast Cancer Liquid Biopsy Market Share by Players (2020-2025)

Table 18. Global Top Breast Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Liquid Biopsy as of 2024)

Table 19. Ranking of Global Top Breast Cancer Liquid Biopsy Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Breast Cancer Liquid Biopsy Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Breast Cancer Liquid Biopsy, Headquarters and Area Served

Table 22. Global Key Players of Breast Cancer Liquid Biopsy, Product and Application

Table 23. Global Key Players of Breast Cancer Liquid Biopsy, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Breast Cancer Liquid Biopsy Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2020-2025)

Table 27. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2026-2031)

Table 29. Global Breast Cancer Liquid Biopsy Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Breast Cancer Liquid Biopsy Revenue Market Share by Application (2020-2025)

Table 31. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Breast Cancer Liquid Biopsy Revenue Market Share by Application (2026-2031)

Table 33. North America Breast Cancer Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Breast Cancer Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Breast Cancer Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Breast Cancer Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Breast Cancer Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Breast Cancer Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Breast Cancer Liquid Biopsy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Breast Cancer Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Breast Cancer Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Breast Cancer Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Breast Cancer Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2026-2031) & (US$ Million)

Table 48. QIAGEN Company Details

Table 49. QIAGEN Business Overview

Table 50. QIAGEN Breast Cancer Liquid Biopsy Product

Table 51. QIAGEN Revenue in Breast Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 52. QIAGEN Recent Development

Table 53. Roche Diagnostics Company Details

Table 54. Roche Diagnostics Business Overview

Table 55. Roche Diagnostics Breast Cancer Liquid Biopsy Product

Table 56. Roche Diagnostics Revenue in Breast Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 57. Roche Diagnostics Recent Development

Table 58. Bio-Rad Laboratories Company Details

Table 59. Bio-Rad Laboratories Business Overview

Table 60. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product

Table 61. Bio-Rad Laboratories Revenue in Breast Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 62. Bio-Rad Laboratories Recent Development

Table 63. Myriad Genetics Company Details

Table 64. Myriad Genetics Business Overview

Table 65. Myriad Genetics Breast Cancer Liquid Biopsy Product

Table 66. Myriad Genetics Revenue in Breast Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 67. Myriad Genetics Recent Development

Table 68. Menarini Silicon Biosystems Company Details

Table 69. Menarini Silicon Biosystems Business Overview

Table 70. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product

Table 71. Menarini Silicon Biosystems Revenue in Breast Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 72. Menarini Silicon Biosystems Recent Development

Table 73. Genomic Health Company Details

Table 74. Genomic Health Business Overview

Table 75. Genomic Health Breast Cancer Liquid Biopsy Product

Table 76. Genomic Health Revenue in Breast Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 77. Genomic Health Recent Development

Table 78. Thermo Fisher Scientific Company Details

Table 79. Thermo Fisher Scientific Business Overview

Table 80. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product

Table 81. Thermo Fisher Scientific Revenue in Breast Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 82. Thermo Fisher Scientific Recent Development

Table 83. Illumina Company Details

Table 84. Illumina Business Overview

Table 85. Illumina Breast Cancer Liquid Biopsy Product

Table 86. Illumina Revenue in Breast Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 87. Illumina Recent Development

Table 88. Biocept Company Details

Table 89. Biocept Business Overview

Table 90. Biocept Breast Cancer Liquid Biopsy Product

Table 91. Biocept Revenue in Breast Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 92. Biocept Recent Development

Table 93. Trovagene Company Details

Table 94. Trovagene Business Overview

Table 95. Trovagene Breast Cancer Liquid Biopsy Product

Table 96. Trovagene Revenue in Breast Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 97. Trovagene Recent Development

Table 98. Guardant Health Company Details

Table 99. Guardant Health Business Overview

Table 100. Guardant Health Breast Cancer Liquid Biopsy Product

Table 101. Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 102. Guardant Health Recent Development

Table 103. RainDance Technologies Company Details

Table 104. RainDance Technologies Business Overview

Table 105. RainDance Technologies Breast Cancer Liquid Biopsy Product

Table 106. RainDance Technologies Revenue in Breast Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 107. RainDance Technologies Recent Development

Table 108. MDx Health Company Details

Table 109. MDx Health Business Overview

Table 110. MDx Health Breast Cancer Liquid Biopsy Product

Table 111. MDx Health Revenue in Breast Cancer Liquid Biopsy Business (2020-2025) & (US$ Million)

Table 112. MDx Health Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Breast Cancer Liquid Biopsy Picture

Figure 2. Global Breast Cancer Liquid Biopsy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Breast Cancer Liquid Biopsy Market Share by Type: 2024 VS 2031

Figure 4. Circulating Tumor Cells (CTCs) Features

Figure 5. Cell-Free DNA (CfDNA) Features

Figure 6. Extracellular Vesicles (EVs) Features

Figure 7. Other Circulating Biomarkers Features

Figure 8. Global Breast Cancer Liquid Biopsy Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Breast Cancer Liquid Biopsy Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Case Studies

Figure 11. Diagnostic Centers Case Studies

Figure 12. Laboratories Case Studies

Figure 13. Breast Cancer Liquid Biopsy Report Years Considered

Figure 14. Global Breast Cancer Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Breast Cancer Liquid Biopsy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Breast Cancer Liquid Biopsy Market Share by Region: 2024 VS 2031

Figure 17. Global Breast Cancer Liquid Biopsy Market Share by Players in 2024

Figure 18. Global Top Breast Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Liquid Biopsy as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Breast Cancer Liquid Biopsy Revenue in 2024

Figure 20. North America Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Breast Cancer Liquid Biopsy Market Share by Country (2020-2031)

Figure 22. United States Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Breast Cancer Liquid Biopsy Market Share by Country (2020-2031)

Figure 26. Germany Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Breast Cancer Liquid Biopsy Market Share by Region (2020-2031)

Figure 34. China Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Breast Cancer Liquid Biopsy Market Share by Country (2020-2031)

Figure 42. Mexico Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Breast Cancer Liquid Biopsy Market Share by Country (2020-2031)

Figure 46. Turkey Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Breast Cancer Liquid Biopsy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. QIAGEN Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2020-2025)

Figure 50. Roche Diagnostics Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2020-2025)

Figure 51. Bio-Rad Laboratories Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2020-2025)

Figure 52. Myriad Genetics Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2020-2025)

Figure 53. Menarini Silicon Biosystems Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2020-2025)

Figure 54. Genomic Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2020-2025)

Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2020-2025)

Figure 56. Illumina Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2020-2025)

Figure 57. Biocept Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2020-2025)

Figure 58. Trovagene Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2020-2025)

Figure 59. Guardant Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2020-2025)

Figure 60. RainDance Technologies Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2020-2025)

Figure 61. MDx Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions